122 related articles for article (PubMed ID: 18815218)
1. JAK2/Y343/STAT5 signaling axis is required for erythropoietin-mediated protection against ischemic injury in primary renal tubular epithelial cells.
Breggia AC; Wojchowski DM; Himmelfarb J
Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1689-95. PubMed ID: 18815218
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin induces sustained phosphorylation of STAT5 in primitive but not definitive erythrocytes generated from mouse embryonic stem cells.
Tsuji-Takayama K; Otani T; Inoue T; Nakamura S; Motoda R; Kibata M; Orita K
Exp Hematol; 2006 Oct; 34(10):1323-32. PubMed ID: 16982325
[TBL] [Abstract][Full Text] [Related]
3. Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis.
Menon MP; Karur V; Bogacheva O; Bogachev O; Cuetara B; Wojchowski DM
J Clin Invest; 2006 Mar; 116(3):683-94. PubMed ID: 16511603
[TBL] [Abstract][Full Text] [Related]
4. Signal transducers and activators of transcription 5 contributes to erythropoietin-mediated neuroprotection against hippocampal neuronal death after transient global cerebral ischemia.
Zhang F; Wang S; Cao G; Gao Y; Chen J
Neurobiol Dis; 2007 Jan; 25(1):45-53. PubMed ID: 17008107
[TBL] [Abstract][Full Text] [Related]
5. A multi-level model accounting for the effects of JAK2-STAT5 signal modulation in erythropoiesis.
Lai X; Nikolov S; Wolkenhauer O; Vera J
Comput Biol Chem; 2009 Aug; 33(4):312-24. PubMed ID: 19660986
[TBL] [Abstract][Full Text] [Related]
6. Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury.
Salahudeen AK; Haider N; Jenkins J; Joshi M; Patel H; Huang H; Yang M; Zhe H
Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1354-65. PubMed ID: 18385271
[TBL] [Abstract][Full Text] [Related]
7. Kidney-secreted erythropoietin lowers lipidemia via activating JAK2-STAT5 signaling in adipose tissue.
Li J; Yang M; Yu Z; Tian J; Du S; Ding H
EBioMedicine; 2019 Dec; 50():317-328. PubMed ID: 31740386
[TBL] [Abstract][Full Text] [Related]
8. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
[TBL] [Abstract][Full Text] [Related]
9. Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin.
Byts N; Samoylenko A; Fasshauer T; Ivanisevic M; Hennighausen L; Ehrenreich H; Sirén AL
Cell Death Differ; 2008 Apr; 15(4):783-92. PubMed ID: 18259195
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin alleviates post-ischemic injury of rat hearts by attenuating nitrosative stress.
Lu MJ; Chen YS; Huang HS; Ma MC
Life Sci; 2012 May; 90(19-20):776-84. PubMed ID: 22521289
[TBL] [Abstract][Full Text] [Related]
11. JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways.
Shi J; Yuan B; Hu W; Lodish H
Exp Hematol; 2016 Nov; 44(11):1044-1058.e5. PubMed ID: 27473563
[TBL] [Abstract][Full Text] [Related]
12. Aldose reductase pathway mediates JAK-STAT signaling: a novel axis in myocardial ischemic injury.
Hwang YC; Shaw S; Kaneko M; Redd H; Marrero MB; Ramasamy R
FASEB J; 2005 May; 19(7):795-7. PubMed ID: 15746188
[TBL] [Abstract][Full Text] [Related]
13. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
[TBL] [Abstract][Full Text] [Related]
14. A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis.
Wakao H; Chida D; Damen JE; Krystal G; Miyajima A
Biochem Biophys Res Commun; 1997 May; 234(1):198-205. PubMed ID: 9168989
[TBL] [Abstract][Full Text] [Related]
15. The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage.
Yoo SJ; Cho B; Lee D; Son G; Lee YB; Soo Han H; Kim E; Moon C; Moon C
Cell Death Dis; 2017 Aug; 8(8):e3003. PubMed ID: 28817120
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin prevents dialysis fluid-induced apoptosis of mesothelial cells.
Vorobiov M; Malki M; Shnaider A; Basok A; Rogachev B; Lewis EC; Chaimovitz C; Zlotnik M; Douvdevani A
Perit Dial Int; 2008; 28(6):648-54. PubMed ID: 18981397
[TBL] [Abstract][Full Text] [Related]
17. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation.
Erickson-Miller CL; Pelus LM; Lord KA
Stem Cells; 2000; 18(5):366-73. PubMed ID: 11007921
[TBL] [Abstract][Full Text] [Related]
18. Does erythropoietin have a dark side? Epo signaling and cancer cells.
Sytkowski AJ
Sci STKE; 2007 Jul; 2007(395):pe38. PubMed ID: 17636183
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats.
Sola A; Rogido M; Lee BH; Genetta T; Wen TC
Pediatr Res; 2005 Apr; 57(4):481-7. PubMed ID: 15718373
[TBL] [Abstract][Full Text] [Related]
20. [Effect of angelica polysaccharides co-erythropoietin on JAK2/STAT5 signal transduction pathway in hematopoietic stem/progenitor cells].
Hua Z; Song S; Luo C; Wang J; Wang Y
Zhongguo Zhong Yao Za Zhi; 2009 Dec; 34(24):3268-71. PubMed ID: 20353016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
